Barsheshet, Y.; Voloshin, T.; Brant, B.; Cohen, G.; Koren, L.; Blatt, R.; Cahal, S.; Haj Khalil, T.; Zemer Tov, E.; Paz, R.;
et al. Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model. Int. J. Mol. Sci. 2022, 23, 14073.
https://doi.org/10.3390/ijms232214073
AMA Style
Barsheshet Y, Voloshin T, Brant B, Cohen G, Koren L, Blatt R, Cahal S, Haj Khalil T, Zemer Tov E, Paz R,
et al. Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model. International Journal of Molecular Sciences. 2022; 23(22):14073.
https://doi.org/10.3390/ijms232214073
Chicago/Turabian Style
Barsheshet, Yiftah, Tali Voloshin, Boris Brant, Gadi Cohen, Lilach Koren, Roni Blatt, Shay Cahal, Tharwat Haj Khalil, Efrat Zemer Tov, Rom Paz,
and et al. 2022. "Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model" International Journal of Molecular Sciences 23, no. 22: 14073.
https://doi.org/10.3390/ijms232214073
APA Style
Barsheshet, Y., Voloshin, T., Brant, B., Cohen, G., Koren, L., Blatt, R., Cahal, S., Haj Khalil, T., Zemer Tov, E., Paz, R., Klein-Goldberg, A., Tempel-Brami, C., Jacobovitch, S., Volodin, A., Kan, T., Koltun, B., David, C., Haber, A., Giladi, M.,
... Palti, Y.
(2022). Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model. International Journal of Molecular Sciences, 23(22), 14073.
https://doi.org/10.3390/ijms232214073